Rosemarie Lajara MD, FACE

Southern Endocrinology Associates

Appearances

Rethinking Treatment Limits—Expanding CGM to Improve Outcomes in Glucose Management—Presented by Abbott
Date
June 24, 2023
Speaker
Rosemarie Lajara, MD, FACE
Southern Endocrinology Associates
Jardiance® (empagliflozin) Tablets: A Review of Multiple Clinical Trials and Approved Indications—Presented by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA LLC
Date
June 22, 2024
Speaker
Rosemarie Lajara, MD, FACE
Southern Endocrinology Associates